January 11, 2024 · Form 4 insider transaction
Claypoole Robert E bought 850,000 shares of Bioventus Incorporated at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
The restricted stock units and options, as applicable, shall vest in four equal installments on each of the first four anniversaries of January 10, 2024, in each case subject to the Reporting Person continuing in service through the applicable vesting date.